| FMOC-D-2-AMINO-5-PHENYL-PENTANOIC ACID |
FMOC-D-2-氨基-5-苯基戊酸 |
1217731-48-0 |
| 3-Chloro-N-{(1S)-2-[(N,N-dimethylglycyl)amino]-1-[(4-{8-[(1S)-1-hydroxyethyl]imidazo[1,2-a]pyridin-2-yl}phenyl)methyl]ethyl}-4-[(1-methylethyl)oxy]benzamide |
3-氯-N-{(1S)-2-[(N,N-二甲基甘氨酰)氨基]-1-[(4-{8-[(1S)-1-羟基乙基]咪唑并[1,2-A]吡啶-2-基}苯基)甲基]乙基}-4-[(1-甲基乙基)氧基]苯甲酰胺 |
1088965-37-0 |
| LDC000067 |
(3-(6-(2-甲氧基苯基)嘧啶-4-基氨基)苯基)甲烷磺酰胺 |
1073485-20-7 |
| 2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-(pent-4-enyl)hept-6-enoic acid |
2-[[(9H-芴-9-基甲氧基)羰基]氨基]-2-(4-戊烯-1-基)-6-庚烯酸 |
1068435-19-7 |
| E-3810 |
德立替尼 |
1058137-23-7 |
| Sofosbuvir |
索非布韦 |
1190307-88-0 |
| CAY10603 |
HDAC6 Inhibitor |
1045792-66-2 |
| Trelagliptin succinate |
琥珀酸曲格列汀 |
1029877-94-8 |
| BMS-794833 |
BMS-794833 |
1174046-72-0 |
| Avagacestat (BMS-708163) |
Avagacestat (BMS-708163) |
1146699-66-2 |
| 6,8-Difluoro-4-pyridin-3-yl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline |
GOLGICIDEA |
1139889-93-2 |
| Cabozantinib Malate |
苹果酸卡博替尼 |
1140909-48-3 |
| AMG-208 |
AMG 208 |
1002304-34-8 |
| N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycylglycylglycylglycine |
N-[(9H-芴-9-基甲氧基)羰基]甘氨酰甘氨酰甘氨酰甘氨酸 |
1001202-16-9 |
| BMS-754807 |
BMS-754807 |
1001350-96-4 |
| LY-2584702 (tosylate salt) |
LY2584702 TOSYLATE |
1082949-68-5 |
| FMOC-D-CHG-OH |
芴甲氧羰酰基D-环己基甘氨酸 |
198543-96-3 |
| Fmoc-N-methyl-O-benzyl-L-threonine |
N-芴甲氧羰酰基-N-甲基-O-苄基-L-苏氨酸 |
198561-81-8 |
| (R)-N-Fmoc-4-Bromophenylalanine |
Fmoc-D-4-溴苯丙氨酸 |
198545-76-5 |
| FMOC-D-2-Fluorophe |
FMOC-D-2-氟苯丙氨酸 |
198545-46-9 |
